CAS 108736-35-2: lanreotide

Description: Lanreotide is a synthetic octapeptide analog of somatostatin, a naturally occurring hormone that inhibits the secretion of several other hormones. It is primarily used in the treatment of acromegaly, a condition characterized by excessive growth hormone production, and for managing certain neuroendocrine tumors. Lanreotide functions by binding to somatostatin receptors, leading to a decrease in growth hormone and insulin-like growth factor 1 (IGF-1) levels. The substance is typically administered via subcutaneous injection and has a prolonged half-life, allowing for less frequent dosing compared to other treatments. Lanreotide is known for its stability and solubility in aqueous solutions, which facilitates its use in clinical settings. Common side effects may include gastrointestinal disturbances, such as diarrhea and abdominal pain, as well as potential impacts on glucose metabolism. Overall, lanreotide represents an important therapeutic option in the management of specific endocrine disorders, demonstrating the significance of peptide-based drugs in modern medicine.

Formula: C₅₄H₆₉N₁₁O₁₀S₂

InChI: InChI=1/C54H69N11O10S2/c1-29(2)45-54(75)63-44(53(74)65-46(30(3)66)47(57)68)28-77-76-27-43(62-48(69)38(56)23-32-15-18-33-10-4-5-11-34(33)22-32)52(73)60-41(24-31-16-19-36(67)20-17-31)50(71)61-42(25-35-26-58-39-13-7-6-12-37(35)39)51(72)59-40(49(70)64-45)14-8-9-21-55/h4-7,10-13,15-20,22,26,29-30,38,40-46,58,66-67H,8-9,14,21,23-25,27-28,55-56H2,1-3H3,(H2,57,68)(H,59,72)(H,60,73)(H,61,71)(H,62,69)(H,63,75)(H,64,70)(H,65,74)

Synonyms:

• B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am
• 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-19-{[3-(naphthalen-2-yl)alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide acetate (1:1)
• 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-16-(4-hydroxybenzyl)-13-(1H-indol-3-ylmethyl)-19-{[3-(naphthalen-2-yl)alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
• Laromustine

Lanreotide

CAS: 108736-35-2

Lanreotide, a cyclic somatostatin agonist shows a high binding affinity for the somatostatin receptor (SSTR) …

• Formula: C₅₄H₆₉N₁₁O₁₀S₂
• Purity: 99.4%
• Color and Shape: White
• Molecular weight: 1096.34

L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide

CAS: 108736-35-2

• Formula: C₅₄H₆₉N₁₁O₁₀S₂
• Purity: 95%
• Color and Shape: Solid
• Molecular weight: 1096.3233600000005

Lanreotide Ditrifluoroacetate

CAS: 108736-35-2

• Formula: C₅₄H₆₉N₁₁O₁₀S₂C₂HF₃O₂
• Molecular weight: 1096.33 2*114.02

Lanreotide

CAS: 108736-35-2

Lanreotide, a somatostatin analogue, suppresses GH/IGF-I hypersecretion in acromegaly patients. It also used to manage …

• Formula: C₅₄H₆₉N₁₁O₁₀S₂
• Color and Shape: Solid
• Molecular weight: 1096.32

Lanreotide-d8

CAS: 108736-35-2

• Formula: C₅₄H₆₁D₈N₁₁O₁₀S₂
• Molecular weight: 1104.38

Lanreotide

CAS: 108736-35-2

• Color and Shape: Solid
• Molecular weight: 1,096.32g/mol